<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Envoy Medical Inc. — News on 6ix</title>
<link>https://6ix.com/company/envoy-medical-inc</link>
<description>Latest news and press releases for Envoy Medical Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/envoy-medical-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835580178dffbe2df0ea6c1.webp</url>
<title>Envoy Medical Inc.</title>
<link>https://6ix.com/company/envoy-medical-inc</link>
</image>
<item>
<title>Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reaches-critical-milestone-in-pivotal-clinical-trial-of-fully-implanted-acclaimr-cochlear-implant</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reaches-critical-milestone-in-pivotal-clinical-trial-of-fully-implanted-acclaimr-cochlear-implant</guid>
<pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
<description>All 56 Enrolled Subjects Have Been Through Their Activation Visit Firming Up Study Timeline White Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) -</description>
</item>
<item>
<title>Envoy Medical Appoints Chas McKhann to Board of Directors</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-appoints-chas-mckhann-to-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-appoints-chas-mckhann-to-board-of-directors</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>Proven Med Tech Leader with an Established Track Record of Commercial Success and Optimizing Shareholder Value Leading to over $3.4 Billion in Successful</description>
</item>
<item>
<title>Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-first-patients-successfully-reaching-12-month-endpoint-in-pivotal-clinical-trial-for-fully-implanted-cochlear-implant</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-first-patients-successfully-reaching-12-month-endpoint-in-pivotal-clinical-trial-for-fully-implanted-cochlear-implant</guid>
<pubDate>Wed, 01 Apr 2026 04:00:00 GMT</pubDate>
<description>Company Remains on Schedule for PMA Submission to FDA White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH)</description>
</item>
<item>
<title>Envoy Medical Reports Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reports-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reports-full-year-2025-financial-results</guid>
<pubDate>Mon, 23 Mar 2026 12:30:00 GMT</pubDate>
<description>Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end, closed on transformational capital raise led by established institutional healthcare investors and completed enrollment of Pivotal Clinical Trial for first-of-its-kind fully implanted cochlear implantWhite Bear Lake, Minnesota--(Newsfile Corp. - March 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH)...</description>
</item>
<item>
<title>Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-completes-enrollment-of-pivotal-clinical-trial-evaluating-first-of-its-kind-fully-implanted-cochlear-implant</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-completes-enrollment-of-pivotal-clinical-trial-evaluating-first-of-its-kind-fully-implanted-cochlear-implant</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA Approval</description>
</item>
<item>
<title>Envoy Medical Regains Compliance with Nasdaq Listing Requirement</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-regains-compliance-with-nasdaq-listing-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-regains-compliance-with-nasdaq-listing-requirement</guid>
<pubDate>Tue, 24 Feb 2026 13:00:00 GMT</pubDate>
<description>White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(2) through the alternatives permitted under Listing Rule 5550(b).As previously disclosed, the Company..</description>
</item>
<item>
<title>Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-secures-three-new-patents-strengthening-competitive-position-in-the-fully-implanted-hearing-space</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-secures-three-new-patents-strengthening-competitive-position-in-the-fully-implanted-hearing-space</guid>
<pubDate>Mon, 23 Feb 2026 05:00:00 GMT</pubDate>
<description>White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health</description>
</item>
<item>
<title>Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-provides-business-update-following-transformative-financing-and-positive-progress-in-clinical-trial</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-provides-business-update-following-transformative-financing-and-positive-progress-in-clinical-trial</guid>
<pubDate>Thu, 19 Feb 2026 13:00:00 GMT</pubDate>
<description>Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor Closing of $30 million in gross proceeds in upsized offering, with up to an additional $48 Million upon exercise of milestone warrants, provides potential funding through commercialization Company hosting Fireside Chat with Dr. Theodore McRackan, on February 25th at 10 a.m. ET, to discuss his initial experiences as clinical trial's leading...</description>
</item>
<item>
<title>Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-nears-completion-enrollment-130000039</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-nears-completion-enrollment-130000039</guid>
<pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
<description>45 of 56 Patients Implanted; Enrollment Completion Anticipated by End of MarchWhite Bear Lake, Minnesota--(Newsfile Corp. - February 17, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced continued progress in enrollment for its pivotal clinical trial of the investigational fully implanted Acclaim® cochlear implant.To date, 45 patients have been successfully implanted and are...</description>
</item>
<item>
<title>Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-closing-78-210500100</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-closing-78-210500100</guid>
<pubDate>Thu, 12 Feb 2026 21:05:00 GMT</pubDate>
<description>$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cashOffering led by Nantahala Capital, with participation of healthcare-dedicated funds, including Broadfin Holdings, and participation from existing shareholder, Glen Taylor, and members of the Company's board of directors and managementNet proceeds extend anticipated cash runway into second half of 2027, beyond expected PMA submission; if</description>
</item>
<item>
<title>Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-pricing-78-142500729</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-pricing-78-142500729</guid>
<pubDate>Wed, 11 Feb 2026 14:25:00 GMT</pubDate>
<description>$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cashWhite Bear Lake, Minnesota--(Newsfile Corp. - February 11, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the pricing of an upsized public offering of an aggregate of 75,000,000 shares of its Class A common stock (or...</description>
</item>
<item>
<title>Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-present-small-cap-133500830</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-present-small-cap-133500830</guid>
<pubDate>Thu, 29 Jan 2026 13:35:00 GMT</pubDate>
<description>WHITE BEAR LAKE, Minn., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Envoy Medical® Inc. (NASDAQ: COCH) (“Envoy Medical” or the “Company”), a hearing health company pioneering fully implanted hearing solutions, today announced that management will participate in the Small Cap Growth Virtual Investor Conference on February 5, 2026. Small Cap Growth Virtual Investor Conference Presentation Details:Date: Thursday, February 5, 2026Time: 10:00 A.M. ETREGISTER HERE A question-and-answer session will follow the p</description>
</item>
<item>
<title>Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reaches-enrollment-milestone-130000539</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reaches-enrollment-milestone-130000539</guid>
<pubDate>Thu, 18 Dec 2025 13:00:00 GMT</pubDate>
<description>Enrollment momentum accelerates as Company advances toward full enrollmentWhite Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that its pivotal clinical study for the investigational fully implanted Acclaim® cochlear implant has achieved yet another milestone by reaching the midway point of the study's full enrollment...</description>
</item>
<item>
<title>Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-secures-australian-patent-130000476</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-secures-australian-patent-130000476</guid>
<pubDate>Tue, 16 Dec 2025 13:00:00 GMT</pubDate>
<description>Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantagesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of Australian Patent No. 2022229818, granted by the Australian Patent Office on October 16, 2025.The.</description>
</item>
<item>
<title>Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-completes-first-set-130000471</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-completes-first-set-130000471</guid>
<pubDate>Wed, 10 Dec 2025 13:00:00 GMT</pubDate>
<description>Momentum continues to build for Company as series of clinical milestones are met, design choices cement differentiation from competition, and timeline comes into focusWhite Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the completion of the first set of activations in the final stage of the pivotal clinical study for the...</description>
</item>
<item>
<title>Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-host-fireside-chat-130000471</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-host-fireside-chat-130000471</guid>
<pubDate>Thu, 04 Dec 2025 13:00:00 GMT</pubDate>
<description>Event to Take Place December 11th at 4:30 P.M. ETWhite Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it will host a fireside chat on Thursday, December 11, 2025, at 4:30 P.M. ET featuring a conversation between CEO Brent Lucas and Craig Eggert, the first patient to receive the Acclaim™ cochlear implant. Event: Envoy...</description>
</item>
<item>
<title>Envoy Medical Announces the Grant of Its 40th U.S. Patent</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-grant-40th-130000952</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-announces-grant-40th-130000952</guid>
<pubDate>Tue, 02 Dec 2025 13:00:00 GMT</pubDate>
<description>New Patent Adds to Company's Growing Portfolio of Intellectual Property Focused on Fully Implanted Hearing DevicesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 2, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received its 40th active U.S. Patent from the United States Patent and Trademark Office. The new patent further strengthens the Company's...</description>
</item>
<item>
<title>Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-secures-u-patent-130000159</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-secures-u-patent-130000159</guid>
<pubDate>Thu, 20 Nov 2025 13:00:00 GMT</pubDate>
<description>Patent adds to Envoy Medical's expanding intellectual property portfolio, reinforcing the Company's leadership in next generation cochlear implant innovationWhite Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of U.S. Patent No. 12,465,754, granted by the United States Patent and Trademark Office (USPTO) on...</description>
</item>
<item>
<title>Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-achieves-six-month-130000282</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-achieves-six-month-130000282</guid>
<pubDate>Tue, 18 Nov 2025 13:00:00 GMT</pubDate>
<description>The trials expansion highlights the Company's clinical momentum and growing confidence in the device's adoption and Company's commercial strategyWhite Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that all 10 patients in the first stage of its pivotal clinical trial for the investigational Acclaim® fully implanted cochlear...</description>
</item>
<item>
<title>Envoy Medical Reports Third Quarter 2025 Financial and Operational Results</title>
<link>https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reports-third-quarter-130000950</link>
<guid isPermaLink="true">https://6ix.com/company/envoy-medical-inc/news/envoy-medical-reports-third-quarter-130000950</guid>
<pubDate>Mon, 10 Nov 2025 13:00:00 GMT</pubDate>
<description>Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition, subsequent to quarter end, the Company received FDA approval to expand its pivotal clinical trial to the final stage, restarted enrollment, and successfully raised additional capitalWhite Bear Lake, Minnesota--(Newsfile Corp. - November 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy...</description>
</item>
</channel>
</rss>